113 related articles for article (PubMed ID: 6439692)
21. [Therapy of multiple myeloma and monitoring of the response].
Rapazzini P; Bettini R; Masini M; Steidl L; Ferrari V; Piantanida S
Recenti Prog Med; 1986 Feb; 77(2):95-9. PubMed ID: 3715177
[No Abstract] [Full Text] [Related]
22. Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation.
Weber DM
Oncology (Williston Park); 2003 Jun; 17(6):765-7. PubMed ID: 12846120
[TBL] [Abstract][Full Text] [Related]
23. [Gamma-D-myeloma. Report of two cases (author's transl)].
Burlando L; Milone S; Acquarone N; Comelli A
Pathologica; 1978; 70(999-1000):39-52. PubMed ID: 418375
[No Abstract] [Full Text] [Related]
24. "Benign" monoclonal IgE gammopathy.
Ludwig H; Vormittag W
Br Med J; 1980 Aug; 281(6239):539-40. PubMed ID: 7427360
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic value of some biochemical and immunologic factors in the management of multiple myeloma].
Abdulkadyrov KM; Stel'mashenko LV; Bessmel'tsev SS; Lubo-Lesnichenko IF; Sel'tser AV; Rozanova OE; Gubarenko NK; Bubnova LN; Mnuskina MM; Zhuchikhina AA; Blinov MN; Gritskevich NL
Vopr Onkol; 1998; 44(3):304-9. PubMed ID: 9695777
[TBL] [Abstract][Full Text] [Related]
26. [Multiple myeloma and HIV/AIDS infection. Three case reports].
Elira Dokekias A; Purhuence MF; Malanda F; Moyikoua A; Moutschen M
Tunis Med; 2004 Jan; 82(1):55-9. PubMed ID: 15125359
[TBL] [Abstract][Full Text] [Related]
27. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
[No Abstract] [Full Text] [Related]
28. Lenalidomide and thalidomide: an evolving paradigm for the management of multiple myeloma.
Anderson KC; Prince HM
Semin Hematol; 2005 Oct; 42(4 Suppl 4):S1-2. PubMed ID: 16344096
[No Abstract] [Full Text] [Related]
29. Familial myeloma. A new observation in two distinct pairs of siblings.
Gobbi PG; Montecucco C; Trespi E; Cavalli C; Gendarini A; Bellotti V; Merlini G; Chèrie-Lignière EL; Ascari E
Haematologica; 1985; 70(4):324-8. PubMed ID: 3935531
[No Abstract] [Full Text] [Related]
30. Multiple eruptive dermatofibromas and immunosuppression: report of two cases and review of the literature.
Zaccaria E; Rebora A; Rongioletti F
Int J Dermatol; 2008 Jul; 47(7):723-7. PubMed ID: 18613883
[TBL] [Abstract][Full Text] [Related]
31. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Yeh YA; Pappas AA; Flick JT; Butch AW
Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
[TBL] [Abstract][Full Text] [Related]
32. Multiple myeloma: the National University Hospital (NUH) experience.
Lim HL; Teo CP; Wong K; Kuperan P; Suri R; Tan YO; Kueh YK
Singapore Med J; 1994 Aug; 35(4):371-3. PubMed ID: 7899894
[TBL] [Abstract][Full Text] [Related]
33. An unusual case of IgE myeloma.
Zavázal V; Sach J; Rozprimová L; Brumelová V
Allergol Immunopathol (Madr); 1978; 6(5):423-6. PubMed ID: 742573
[TBL] [Abstract][Full Text] [Related]
34. Two cases of plasma cell leukemia with atypical immunophenotype.
Buda G; Carulli G; Orciuolo E; Cannizzo E; Zucca A; Azzarà A; Rossi A; Galimberti S; Cecconi N; Petrini M
Acta Haematol; 2007; 118(1):27-9. PubMed ID: 17429194
[No Abstract] [Full Text] [Related]
35. [Multiple myeloma (IgG-kappa) infiltrating central nervous system, lymph nodes, liver, and kidneys, and with elevation of IgE].
Toyota S; Nakamura N; Dan K
Rinsho Ketsueki; 2004 May; 45(5):408-10. PubMed ID: 15199753
[TBL] [Abstract][Full Text] [Related]
36. Immunochemical investigation on myeloma and normal gamma G globulin.
Ferri RG; Prigenzi L
Rev Latinoam Microbiol Parasitol (Mex); 1967; 9(1):5-9. PubMed ID: 4971388
[No Abstract] [Full Text] [Related]
37. A case of IgE-multiple myeloma presenting with a high serum Krebs von den Lungen-6 level.
Hua J; Hagihara M; Inoue M; Iwaki Y
Leuk Res; 2012 May; 36(5):e107-9. PubMed ID: 22425660
[No Abstract] [Full Text] [Related]
38. Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
Van Dobbenburgh OA; Houwen B; Piersma H; Marrink J; Ockhuizen T; Halie MR; Nieweg HO
Neth J Med; 1984; 27(2):25-30. PubMed ID: 6709108
[No Abstract] [Full Text] [Related]
39. T-cell post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: another case and a review of the literature.
Lau LG; Tan LK; Salto-Tellez M; Koay ES; Liu TC
Bone Marrow Transplant; 2004 Nov; 34(9):821-2. PubMed ID: 15354208
[No Abstract] [Full Text] [Related]
40. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
